Why BRF (BRFS) Dipped More Than Broader Market Today

BRF (BRFS) closed down 1.37% at $3.60, underperforming the S&P 500, despite a 2.53% gain over the past month and positive full-year forecasts of $0.39 EPS (+8.33% YoY) and $12.15 billion revenue (+11.05% YoY). The protein producer holds a Zacks Rank #2 (Buy) and trades at a significant valuation discount, with a Forward P/E of 9.36 and PEG ratio of 0.23, against industry averages of 15.08 and 1.6 respectively, though its Food - Miscellaneous industry is in the bottom quartile of Zacks' rankings.

Analysis

While BRF S.A. (BRFS) recently underperformed the broader market with a 1.37% daily decline, its one-month performance of +2.53% has outpaced the Consumer Staples sector. The fundamental outlook presents a contrast between near-term expectations and the full-year forecast. The upcoming quarter's EPS is projected to be flat year-over-year at $0.11, and analyst consensus estimates have remained stagnant over the past month, suggesting a lack of recent upward revisions. However, the full-year outlook is robust, with Zacks Consensus Estimates projecting an 8.33% increase in EPS to $0.39 and an 11.05% rise in revenue to $12.15 billion. The stock's primary appeal lies in its valuation, trading at a significant discount with a Forward P/E of 9.36 versus an industry average of 15.08, and a very low PEG ratio of 0.23 compared to the industry's 1.6. This valuation and positive full-year outlook underpin its Zacks Rank #2 (Buy), though investors should note that BRFS operates in the Food - Miscellaneous industry, which ranks in the bottom 25% of all industries.

Key Decisions for Investors

• Value-oriented investors should consider the stock's compelling valuation, highlighted by a Forward P/E of 9.36 and a PEG ratio of 0.23, which suggests the market may be underpricing its long-term growth prospects.
• Investors should be prepared for potential near-term volatility or sideways movement, given the flat year-over-year EPS forecast for the upcoming quarter and stagnant analyst revisions.
• Closely monitor the upcoming earnings report for confirmation of the full-year growth guidance and any management commentary on overcoming the headwinds associated with its poorly ranked industry.